Home
HEALTH CARE
Allergy and hay fever
Antineoplastic and immunomodulating agents
Circulatory system
Colds and flu
Dermatology
Digestive system
Eyes
For diabetics
Homeopathy
Musculoskeletal system
Non-sex hormones
Nutrikosmetics
Pain
Preparations for the treatment of infections
Sex and contraception
The immune system
The nervous system
Urogenital tract
Vitamins and minerals
HEALTHY LIFESTYLE
For athletes
Healthy food
Slimming
HYGIENE
Disinfection
Ear hygiene
Hot and cold compresses
Intimate hygiene
Laundry products
Oral hygiene
Slices and sticks
Urinary incontinence
COSMETICS
Cosmetic articles
For eyelashes and eyebrows
For face
For hair
For hands and nails
For the body
Soap
Sunbathing
To the feet
To the mouth
FOR HIM
Cosmetics for men
Health
PREGNANCY AND MOTHERHOOD
Accessories
Cosmetics for pregnant women
Health in pregnancy
Supporting fertility
CHILD
Baby nutrition
Child health
Cosmetics for children
Hygiene items for children
Oral hygiene (for children)
Scrolling
HEALTH CARE
Dona, powder for oral solution 30 sachets — Made in Ireland — Free Delivery
Dona, powder for oral solution 30 sachets — Made in Ireland — Free Delivery
Brand:
Rotapharm
Product Code:
Dona
Availability:
In Stock
$50.75
Add to Cart
Description
Product d
escription
DONA® is prescribed to relieve symptoms of mild to moderate osteoarthritis of the knee.
Warehouse
Active ingredient: glucosamine sulfate.
1 sachet contains 1,884 mg of crystalline glucosamine sulfate, which is equivalent to 1,500 mg of glucosamine sulfate and 384 mg of sodium chloride.
Excipients: aspartame (E 951), sorbitol (E 420), citric acid, polyethylene glycol 4000
Contraindications
Hypersensitivity to glucosamine or to any of the excipients; dysfunction of the liver and kidneys in the stage of decompensation, a tendency to bleeding. DONA® should not be used in patients with shellfish allergy, since the active ingredient is obtained from shellfish.
Mode of application
Adult patients and elderly patients dissolve the contents of 1 sachet, equivalent to 1500 mg of glucosamine sulfate in a glass of water and take once a day, preferably with meals.
Glucosamine is not intended to treat acute pain symptoms. Symptom relief (especially pain relief) may only occur after a few weeks of use, and in some cases longer.
If no relief of symptoms has occurred after 2-3 months of administration, treatment should be reconsidered.
Application features
Before using the preparation, it is necessary to consult a doctor to exclude the presence of joint diseases for which other methods of treatment are provided.
Pregnancy
There are no data on the use of the preparation during pregnancy and lactation; therefore, the preparation should not be used in this category of patients.
Children
Do not use in children and adolescents (under 18 years of age), since the safety and efficacy of the preparation for such patients have not been established.
Drivers
The study of the effect of the preparation on the ability to drive a car and other mechanisms has not been conducted. Care should be taken when driving and performing work requiring attention. In case of drowsiness, fatigue, dizziness or visual impairment, driving and operating machinery is prohibited.
Overdose
Overdose cases were not observed with. Given the acute and chronic toxicity studies in animals, symptoms of toxicity are unlikely to occur even when used in doses 200 times the therapeutic dose. However, in case of an overdose, the manifestations of adverse reactions may increase, therefore, it is worthwhile to carry out symptomatic treatment aimed at restoring the water-electrolyte balance.
Side effects
The most common adverse reactions associated with glucosamine use are nausea, abdominal pain, indigestion, flatulence, constipation, diarrhea, headache, fatigue, and drowsiness. These adverse reactions are usually transient and mild.
Interaction
There are limited data on the possible interaction of preparations with glucosamine, however, there was an increase in INR (international normalized recovery) with the use of oral vitamin K antagonists.Therefore, patients receiving oral vitamin K antagonists should be closely monitored during the initiation or discontinuation of glucosamine therapy. Concomitant treatment with glucosamine can enhance absorption and, therefore, the concentration of tetracyclines in serum. However, the clinical relevance of this interaction is likely to be limited.
Given the fact that there are only limited data on the possible interaction of glucosamine, special attention should be paid to any modified reaction to changes in the concentration of concomitant preparations used in serum.
Storage conditions
Keep out of the reach of children at a temperature not exceeding 30 ° C.
Shelf life is 3 years.
0 reviews
There are no reviews for this product.